-
The Applications of 1-Boc-4-(4-methoxycarbonylphenyl)piperazine
Time of Update: 2023-05-16
The use of MCPP as a monomer for polyacrylamide synthesis has led to the development of new materials with improved properties, such as higher molecular weight and better thermal stability.
-
The pattern of the innovative drug industry has become clearer, and there are three points in the layout logic
Time of Update: 2023-01-06
The industry believes that the core of medical insurance is still to encourage innovation, and since the national policy of supporting the development of innovative drugs in 2015, some domestic innovative drugs that appeared in 2018-2019 are some generic innovations that lack special value.
-
The pattern of the innovative drug industry has become clearer, and there are three points in the layout logic
Time of Update: 2023-01-06
The industry believes that the core of medical insurance is still to encourage innovation, and since the national policy of supporting the development of innovative drugs in 2015, some domestic innovative drugs that appeared in 2018-2019 are some generic innovations that lack special value.
-
International slow grain daily domestic original innovative drugs passed the medical insurance form review! Drug-resistant patients do not need a "medicine god
Time of Update: 2022-10-01
02 Clinical data from 0 to 1 to fill the domestic treatment gap shows the best potential in the same category In November 2021, the State Drug Administration of China conditionally approved the listing of the class 1 innovative drug orebatinib tablets declared by Yasheng Pharmaceutical through the priority review and approval procedure, filling the treatment gap for patients with T315I mutation slow grain in China.
-
With the continuous expansion of the Chinese medicine formula granule test market, two major issues cannot be ignored
Time of Update: 2021-12-08
On November 1, the State Food and Drug Administration and other departments ended the more than 20-year pilot work of traditional Chinese medicine formula granules, and officially launched the registration module of traditional Chinese medicine formula granules .
-
Functional cosmetics are also insured, how can "drugs and cosmetics" be sold under the new supervision
Time of Update: 2021-06-30
In addition to the late start, another reason is that China's functional cosmetics market is mainly online, and the offline market based on professional pharmacies is still in an earlier stage of development .
-
Marken acquires three European logistics companies to advance the clinical trial supply chain layout
Time of Update: 2021-02-26
Marken is committed to providing home health care to patients and provides state-of-the-art GMP-compliant warehouse networks and logistics centers in 51 locations in 26 countries for the storage and distribution of clinical trial materials.
-
Stone Pharmaceutical Group 2 heavy-weight varieties have been over-evaluated
Time of Update: 2020-11-05
Medicine Network October 29 - October 26, the Official Website of the State Drug Administration shows that Stone Pharmaceutical Group's Nofluosa star tablets, cephalospora capsules through a consistent evaluation.
-
The new crown vaccine is getting closer, and who's going to pay for 1.4 billion people's vaccinations
Time of Update: 2020-10-21
(2020/10/15) Xinda hired Liu Yongjun as group president Junshi core technical personnel Wu Hai left, the development of "blue economy": China's marine biopharmaceutical industry development status quo analysis and research, the introduction of anti-monopoly guidance on raw materials can curb monopoly behavior ...
-
Guizhou Province, Chongqing City, Hainan Province, three provinces join forces to cut prices of supplies
Time of Update: 2020-09-03
Pharmaceutical Network August 14th, August 12th, Guizhou Province pharmaceutical centralized procurement platform released the "Guizhou Provincial Medical Security Bureau Chongqing Municipal Medical S
-
Medical and Health Industry Weekly (July 20 - July 24
Time of Update: 2020-08-02
Joint release: Sina Pharmaceuticals, Sadie Consultants One Week Overview: Policy and regulations, the State Council issued "Deepening the reform of the medical and health system in the second half of
-
Drug Curry Jun inhaling preparations is expected to break the monopoly of foreign enterprises! Section 7 PD-1 single anti-declaration listing; Collum first imitation is about to be approved, health
Time of Update: 2020-07-30
Read: The Latest! New Developments for the Week of Drug Review !---- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. Health meta-inhalation large variet
-
Enhua children's new products to be priority review Exclusive declaration impact of domestic first imitation
Time of Update: 2020-07-16
Pharmaceutical Network July 15th, July 13, CDE official website announced the latest proposed priority review varieties, Enhua Pharmaceuticals hydrochloric acid Midazole syrup (acceptance of CYHS20003
-
Nearly 18.4 billion painkiller market, two domestic enterprises into the top three sales
Time of Update: 2020-07-15
" Pharmaceutical Network Market Analysis " Recently, Yangzijiang's hydrochloric acid nabutyl injection 3 class of generic listing application was accepted by CDE, the product is currently only a ble
-
What are the gods-level figures of the Experts outside the CDE
Time of Update: 2020-07-09
CDE this time under the "big effort", the external 626 experts, of which 35 are academicians! On 5 June , the CDE website updated a circular on the publication of the Measures for the Administration o
